郑树森附属第一医院 | 医学院临床医学· 器官移植· 肝胆胰外科个人简介:    郑树森，中国工程院院士、法国国家医学科学院外籍院士、浙江大学外科学教授。现任中国医学科学院器官移植诊治重点实验室主任，浙江大学学术委员会副主任、浙江大学器官移植研究所所长、浙江大学附属第一医院学术委员会主任、肝胆胰外科主任，中华医学会副会长、中国医师协会副会长、中国医师协会器官移植医师分会会长，美国外科医师协会会员（FACS），国际活体肝移植执行委员会委员，国际肝胆胰协会委员。    在器官移植和肝胆胰外科领域成绩卓著，在国际上首次提出肝癌肝移植受者选择的“杭州标准”及移植后乙肝复发防治新方案。截止2018年7月，成功施行肝移植2800余例，受者生存率达国际先进水平；多年来致力于肝移植技术的创新和推广应用，2010年率中国肝移植团队跨出国门，远赴印度尼西亚成功开展5例活体肝移植，为国争光，被高度评价为器官移植外交的里程碑。担任器官移植领域2项 “973计划”项目首席科学家，主持国家科技重大专项课题、国家自然科学基金重点项目、教育部长江学者和创新团队发展计划等。发表论文600余篇，任《国际肝胆胰疾病杂志》（SCI收录）主编、《中华移植杂志》（电子版）总编辑。    荣获国家科技进步特等奖1项、一等奖(含创新团队奖)2项、国家科技进步二等奖2项、荣获2013年度何梁何利基金“科学与技术进步奖”，主持的“肝癌肝移植新型分子分层体系研究”这项创新性研究获得2016年度中国高等学校十大科技进展，荣获2016年度中央电视台年度科技创新人物。教学与课程:博士生课程：           肝移植研究进展           胰腺移植进展硕士生课程：           肝移植研究进展           胰腺移植进展本科生课程：           肝脏疾病留学生课程：           Liver八年制课程：           肝癌           肝病进展研究与成果:科研项目1.国家重点基础研究发展规划（973计划） “移植器官慢性失功的免疫学应用基础研究” 2003.12-2008.082.国家重点基础研究发展规划（973计划）“器官移植的免疫学应用基础研究--肝脏免疫微环境影响肝移植术后乙肝复发的机制和干预研究”2009.01 -2013.083.国家科技重大专项 “肝癌抗复发转移治疗临床新体系的研究及应用”2008.10 -2010.124.卫生部公益性行业科研专项基金 “器官移植的临床诊治与推广项目” 2007.01－2009.125.国家重点基础研究发展规划（973计划）子课题“肠道微生态失衡与移植感染相关性研究” 2007.01 -2011.126.国家自然科学基金重点项目 “肝移植术后免疫调节网络在乙肝病毒免疫逃逸中的机制研究”2008.01 -2011.12 7.国家自然科学基金国际合作课题 “肝癌肝移植病人循环癌细胞生物标记物的研究”2007.01－2010.12  8.卫生部公益性行业科研专项基金子课题 “门静脉高压症治疗方法的合理选择和推广应用” 2011.01－2013.12 9.卫生部公益性行业科研专项基金子课题 “心脏死亡供者器官活力评价、体外修复及肝移植关键技术标准的建立、优化与推广” 2011.01－2013.1210.国家高技术研究发展计划（863计划）子课题 “纳米血管替代物及胆道支架的研发” 2008.01－2010.1211.国家自然科学基金创新研究群体“人工肝与肝移植治疗终末期肝病的基础应用研究” 2012.01 -2014.1212.国家科技重大专项（艾滋病和病毒性肝炎等重大传染病防治）“肝癌抗复发转移治疗临床新体系的研究和应用推广（首席）” 2013.01 -2015.1213.浙江省科技厅 重大专项“肝胆胰外科常见疾病规范化诊疗技术成果转化工程 ”，2013年立项14.国家自然科学基金创新研究群体延续资助“人工肝与肝移植治疗终末期肝病的基础应用研究” 2015.01 -2017.1215.国家自然科学基金重大研究计划，肝脏树突状细胞在移植肝区域免疫中的作用及机制研究2016.01-2019.1216.浙江省科技计划项目，中—印尼肝移植与乙肝相关性肝病综合治疗的科技创新研究中心2017.01-2020.1217.国家自然科学基金创新研究群体延续资助“人工肝与肝移植治疗终末期肝病的基础应用研究” 2018.01 -2020.12发表论文2016年至2018年07月发表文章Xu L Xu S Wang H Zhang J Chen Z Pan L Wang J Wei X Xie H Zhou L Zheng S Xu X. Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design Nanoparticle Encapsulation and Cancer Cell-Specific Drug Targeting. ACS Appl Mater Interfaces. 2018 Jan 31;10(4):3229-3240. Ding SM Lu AL Zhang W Zhou L Xie HY Zheng SS Li QY.  The role of cancer-associated fibroblast MRC-5 in pancreatic cancer. J Cancer. 2018 Jan 5;9(3):614-628. Sun JH Zhang YL Nie CH Li J Zhou TY Zhou GH Zhu TY Chen LM Wang WL Zheng SS. Effects of liver cirrhosis on portal vein embolization prior to right hepatectomy in patients with primary liver cancer. Oncol Lett. 2018 Feb;15(2):1411-1416. Li JH Jia JJ Shen W Chen SS Jiang L Xie HY Zhou L Zheng SS. Optimized postconditioning algorithm protects liver graft after liver transplantation in rats. Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):32-38. Huang Y Kong Y Zhang L He T Zhou X Yan Y Zhang L Zhou D Lu S Zhou JZhou L Xie H Zheng S Wang W. High Expression of ITGA3 Promotes Proliferation and Cell Cycle Progression and Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. Biomed Res Int. 2018 Feb 4;2018:2352139. Liu Z Li J Chen J Shan Q Dai H Xie H Zhou L Xu X Zheng S. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression. BMC Cancer. 2018 Feb 20;18(1):200. Zhou B Zhan C Ding Y Yan S Zheng S. Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis. Onco Targets Ther. 2018 Feb 23;11:975-982. Lu D Wang W Liu J Qi L Zhuang R Zhuo J Zhang X Xu X Zheng S. Peroxiredoxins in inflammatory liver diseases and ischemic/reperfusion injury in liver transplantation. Food Chem Toxicol. 2018 Mar;113:83-89. Chen Y Wei H Liu Y Zheng S. Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7. Oncol Lett. 2018 Apr;15(4):4439-4444. Du F Yu Y Zhou Z Wang L Zheng S. Early treatment using fractional CO2 laser before skin suture during scar revision surgery in Asians. J Cosmet Laser Ther. 2018 Apr;20(2):102-105. Yang B Tong R Liu H Wu J Chen D Xue Z Ding C Zhou L Xie H Wu J Zheng S. H2A.Z regulates tumorigenesis metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma. Int J Oncol. 2018 Apr;52(4):1235-1245. Qiao Y Li T Zheng S Wang H. The Hippo pathway as a drug target in gastric cancer. Cancer Lett. 2018 Apr 28;420:14-25. Shi SH Feng XN Wang ZY Sun K Xu JF Kong HS Zheng SS. Pyogenic liver abscess related to intrahepatic bile duct stones: Difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma. J Gastroenterol Hepatol. 2018 May;33(5):1092-1099. Shao Y Yan S Zhang QY Shen Y Zhang M Wang WL Zheng SS. Autologous falciform ligament graft as A substitute for mesentericoportal vein reconstruction in pancreaticoduodenectomy. Int J Surg. 2018 May;53:159-162. Hu X He B Zhou L Zheng S. Elevated TEAD1 Expression is not an Independent Prognosis Factor of Hepatocellular Carcinoma. Clin Lab. 2018 May 1;64(5):743-748. Wang B Zhou TY Nie CH Wan DL Zheng SS. Bigelovin a sesquiterpene lactone suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer.Biochem Biophys Res Commun. 2018 May 5;499(2):156-163. Chen J Song W Du Y Li Z Xuan Z Zhao L Chen J Zhao Y Tuo B Zheng S Song P. Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility arresting cell cycle and reducing Erk activation. Biochem Biophys Res Commun. 2018 May 15;499(3):433-440. Qian YG Ye Z Chen HY Lv Z Zhang AB Fan L Zhou J Zheng SS Wang WL. LINC01121 Inhibits Cell Apoptosis While Facilitating Proliferation Migration and Invasion Though Negative Regulation of the Camp/PKA Signaling Pathway via GLP1R. Cell Physiol Biochem. 2018 May 24;47(3):1007-1024. Wu L Yang F Lin B Chen X Yin S Zhang F Xie H Zhou L Zheng S. MicroRNA-424 expression predicts tumor recurrence in patients with hepatocellular carcinoma following liver transplantation. Oncol Lett. 2018 Jun;15(6):9126-9132. Wang J Tian Y Chen H Li H Zheng S. Key signaling pathways genes and transcription factors associated with hepatocellular carcinoma. Mol Med Rep. 2018 Jun;17(6):8153-8160. Sun J Zhou G Zhang YZheng S Zhou T Nie C Zhu T Chen S Wang B Yu Z Wang H Chen X Hong L Chen L Wang W Zheng S. Comprehensive analysis of common safety profiles and their predictive factors in 520 records of liver cancer patients treated by drug-eluting beads transarterial chemoembolization. Medicine (Baltimore). 2018 Jun;97(26):e11131. Sun W  He B Yang B Hu W Cheng S Xiao H Yang Z Wen X Zhou L Xie H Shen X Wu J Zheng S. Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Lab Invest. 2018 Jun;98(6):734-744. Chen J Zhuo JY Yang F Liu ZK Zhou L Xie HY Xu X Zheng SS. 17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):220-226. Geng L Wang LD Huang JJ Shen T Wang ZY Lin BY Ye YF Zheng SS. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes. Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):204-209. Zhou GH Han J Sun JH Zhang YL Zhou TY Nie CH Zhu TY Chen SQ Wang BQ Yu ZN12 Wang HL Chen LM Wang WL Zheng SS. Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients. BMC Cancer. 2018 Jun 8;18(1):644. Xuan Z Chen J Song P Du Y Wang L Wan D Zheng S. Management of intrahepatic splenosis:a case report and review of the literature. World J Surg Oncol. 2018 Jun 28;16(1):119. Lu D Zhuo J Yang M Wang C Pan L Xie H Xu X Zheng S. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation. Gene. 2018 Jul 15;663:121-125. Meng X Chen X Wu L Zheng S. The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy. J Immunol Res. 2017; 2017:3149426. Liu Z Gao F Shao Z Xie H Zhou L Xu X Zheng S. TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma. Gastroenterol Res Pract. 2017;2017:6353248. Ling Q Xie H Li J Liu J Cao J Yang F Wang C Hu Q Xu X Zheng S. Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation. Am J Transplant. 2017 Jan;17(1):255-264. Xia W Ke Q Guo H Wang W Zhang M Shen Y Wu J Xu X Yan S Yu J Zhang M Zheng S. Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio. BMC Cancer. 2017 Jan 5;17(1):14. Sun JH Zhou GH Zhang YL Nie CH Zhou TY Ai J Zhu TY Wang WL Zheng SS. Chemoembolization of liver cancer with drug-loading microsphere 50-100μm. Oncotarget. 2017 Jan 17;8(3):5392-5399. Meng XQ Chen XH Sahebally Z Xu YN Yin SY Wu LM Zheng SS. Cytokines are early diagnostic biomarkers of graft-versus-host disease in liver recipients. Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):45-51. Bai YF Liu JM Zhang XM Jiang CZ Xu X Zheng SS. Percutaneous liver biopsy: retrospective study of primary and secondary hepatic lymphoma in twenty-one patients. Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):58-64. Zhang A Qian Y Ye Z Chen H Xie H Zhou L Shen Y Zheng S. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med. 2017 Feb;6(2):463-470. Ling Q Dai H Zhuang R Shen T Wang W Xu X Zheng S.  Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry. Sci Rep. 2017 Feb 13;7:42253. Chen HY Chen YM Wu J Yang FC Lv Z Qian YG Zheng SS. Effects of HGF gene polymorphisms and protein expression on transhepatic arterial chemotherapeutic embolism efficacy and prognosis in patients with primary liver cancer. Onco Targets Ther. 2017 Feb 13;10:803-810. Ling S Xie H Yang F Shan Q Dai H Zhuo J Wei X Song P Zhou L Xu X Zheng S. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK ERK3 and mTORC1. J Hematol Oncol. 2017 Feb 28;10(1):59. Ge W Zhou D Xu S Wang W Zheng S. Surveillance and comparison of surgical prognosis for asymptomatic and symptomatic non-functioning pancreatic neuroendocrine tumors. Int J Surg. 2017 Mar;39:127-134. Wang H Wu J Xie K Fang T Chen C Xie H Zhou L Zheng S. Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release. ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10567-10576. Hu Z Zhou J Li Z Xiang J Zhang Q Yan S Wu J Zhang M Wang W Zheng S. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score. J Hepatobiliary Pancreat Sci. 2017 Apr;24(4):206-216. Wei Q Nemdharry RS Zhuang RZ Li J Ling Q Wu J Shen T Zhou L Xie HY Zhang M Xu X Zheng SS. A good prognostic predictor for liver transplantation recipients with benign end-stage liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):164-168. Fu P Du F Liu Y Yao M Zhang S Zheng X Zheng S. WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells. Am J Transl Res. 2017 Apr 15;9(4):1783-1791. Fang JF Zhao HP Wang ZF Zheng SS. Upregulation of RASAL2 promotes proliferation and metastasis and is targeted by miR-203 in hepatocellular carcinoma. Mol Med Rep. 2017 May;15(5):2720-2726. Shi SH Feng XN Lai MC Kong HS Zheng SS. Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Liver Int. 2017 May;37(5):727-734. Ling S Li J Shan Q Dai H Lu D Wen X Song P Xie H Zhou L Liu J Xu X Zheng S. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Mol Oncol. 2017 Jun;11(6):682-695. Zhang AB Wang Y Hu C Shen Y Zheng SS. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center experience. J Zhejiang Univ Sci B. 2017 Jun;18(6):532-538. Ye YF Wang W Wang T Yu J Geng L Yu SF Yan S Zheng SS. Role of 18F fludeoxyglucose positron emission tomography in the selection of liver transplantation candidates in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2017 Jun;16(3):257-263. Tong R Yang B Xiao H Peng C Hu W Weng X Cheng S Du C Lv Z Ding C Zhou L Xie H Wu J Zheng S. KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling. Oncotarget. 2017 Jun 6;8(23):37717-37729. Sun JH Zhou TY Zhang YL Zhou GH Nie CH Zhu TY Chen SQ Wang BQ Ye S Shen Y Guo H Wang WL Zheng SS. Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer. Oncotarget.2017 Jun 13;8(24):39746-39755. Peng C Hu W Weng X Tong R Cheng S Ding C Xiao H Lv Z Xie H Zhou L Wu J Zheng S. Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8. Sci Rep. 2017 Jun 23;7(1):4186. Chen X Chen Y Jiang J Wu L Yin S Miao X Swanson RJ Zheng S. Nano-pulse stimulation (NPS) ablate tumors and inhibit lung metastasis on both canine spontaneous osteosarcoma and murine transplanted hepatocellular carcinoma with high metastatic potential. Oncotarget. 2017 Jul 4;8(27):44032-44039. Yang Z Jin Q Hu W Dai L Xue Z Man D Zhou L Xie H Wu J Zheng S. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration invasion and anoikis resistance of ICC cells. Cancer Biomark. 2017 Jul 4;19(3):313-325.Wu L Zhang L Zheng S. Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma. Oncol Lett. 2017 Aug;14(2):1233-1239. Lai MC Zhu QQ Owusu-Ansah KG Zhu YB Yang Z Xie HY Zhou L Wu LM Zheng SS. Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation. Oncol Lett. 2017 Aug;14(2):1395-1402. Hu Z Mei S Xiang J Zhou J Li Z Zhou L Yan S Wang W Zheng S. Survival rates after liver transplantation using hypertensive donor grafts: an analysis of the Scientific Registry of Transplant Recipients database. J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):441-448. Geng L Huang JJ Lin BY Chen TC Shen T Zheng SS. Characteristics of recipients with complete immunosuppressant withdrawal after adult liver transplantation. Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):437-439. Zhang Y Liu Y Chen H Zheng X Xie S Chen W Ji H Zheng S. TIM-1 attenuates the protection of ischemic preconditioning for ischemia reperfusion injury in liver transplantation. Am J Transl Res. 2017 Aug 15;9(8):3665-3675. Chen L Sun Q Zhou D Song W Yang Q Ju B Zhang L Xie H Zhou L Hu Z Yao H Zheng S Wang W. HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer. Cancer Lett. 2017 Sep 23;411:106-116. He N Li JH Jia JJ Xu KD Zhou YF Jiang L Lu HH Yin SY Xie HY Zhou L Zheng SS. Hypothermic Machine Perfusions Protection on Porcine Kidney Graft Uncovers Greater Akt-Erk Phosphorylation. Transplant Proc. 2017 Oct;49(8):1923-1929. Liu Z Guo H Gao F Shan Q Li J Xie H Zhou L Xu X Zheng S. Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes. Hepatol Res. 2017 Oct;47(11):1108-1117. Zhou B Zhan C Wu J Liu J Zhou J Zheng S. Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection. Sci Rep. 2017 Oct 17;7(1):13372. Kong Y Zhang L Huang Y He T Zhang L Zhao X Zhou X Zhou D Yan Y Zhou J Xie H Zhou L Zheng S Wang W. Pseudogene PDIA3P1 promotes cell proliferation migration and invasion and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Cancer Lett. 2017 Oct 28;407:76-83. Ling S Shan Q Liu P Feng T Zhang X Xiang P Chen K Xie H Song P Zhou L Liu J Zheng S Xu X. Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I. Cell Death Dis. 2017 Nov 2;8(11):e3159. Wang Z Geng L Chen Z Lin B Zhang M Zheng S. In vivo therapeutic potential of Inula racemosa in hepatic ischemia-reperfusion injury following orthotopic liver transplantation in male albino rats. AMB Express. 2017 Nov 22;7(1):211. Zhou B Zhan C Wu J Liu J Zhou J Zheng S. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors. Med Sci Monit. 2017 Nov 23;23:5574-5588. Zhang W Li F Ye Y Liu Y Yu S Cen C Chen X Zhou L Tang X Yu J Zheng S. Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. Transplantation. 2017 Dec;101(12):2862-2872. Zhou B Deng J Chen L Zheng S. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors. Sci Rep. 2017 Dec 13;7(1):17506. Wang H Lu Z Wang L Guo T Wu J Wan J Zhou L Li H Li Z Jiang D Song P Xie H Zhou L Xu X Zheng S. New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity.  Cancer Res. 2017 Dec 15;77(24):6963-6974. Xi B Jia JJ Lin BY Geng L Zheng SS. Peptic ulcers accompanied with gastrointestinal bleeding pylorus obstruction and cholangitis secondary to choledochoduodenal fistula: A case report. Oncol Lett. 2016;11(1):481-483. Al-raimi K Zheng SS. Postoperative outcomes after open splenectomy versus laparoscopic splenectomy in cirrhotic patients: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2016 ;15(1):14-20. Li Z Sun F Hu Z Xiang J Zhou J Yan S Wu J Zhou L Zheng S. New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database. Transplant Proc. 2016;48(1):138-44. Luo W Ren Z Gao S Jin H Zhang G Zhou L Zheng S. Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma. Oncol Lett. 2016;11(2):1345-1352. Yang F Ren Z Chai Q Cui G Jiang L Chen H Feng Z Chen X Ji J Zhou LWang W Zheng S. A novel biliary stent coated with silver nanoparticles prolongs the unobstructed period and survival via anti-bacterial activity. Sci Rep. 2016;6:21714. Liu Z Chen T Lu X Xie H Zhou L Zheng S. Overexpression of variant PNPLA3 gene at I148M position causes malignant transformation of hepatocytes via IL-6-JAK2/STAT3 pathway in low dose free fatty acid exposure: a laboratory investigation in vitro and in vivo. Am J Transl Res. 2016;8(3):1319-38. Meng XQ Zhang W Zhang F Yin SY Xie HY Zhou L Zheng SS. Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells. Oncol Lett. 2016;11(3):2145-2151. Xu J Zhou BO Cao HL Wang BO Yan S Zheng SS. Surgical management of isolated retroperitoneal Castlemans disease: A case report. Oncol Lett. 2016;11(3):2123-2126. Xu X Liu Z Wang J Xie H Li J Cao J Zhou L Zheng S. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma. Oncotarget. 2016;7(12):13730-41. He ZL Xu X Ke QH Zheng SS. Successful diagnosis of intrahepatic splenosis mimicking hepatic tumor. aohsiung J Med Sci. 2016;32(4):224-5. Yin SY Zhai ZL Ren KW Yang YC Wan DL Liu XY Wang LJ Zheng SS. Porta hepatic schwannoma: case report and a 30-year review of the literature yielding 15 cases. World J Surg Oncol. 2016;14(1):103. Xie H Xu X Chen J Li L Wang J Fang T Zhou L Wang H Zheng S. Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo. Chem Commun (Camb). 2016;52(32):5601-4. Wang B Ren KW Yang YC Wan DL Li XJ Zhai ZL Zhang LL Zheng SS. Carcinosarcoma of the Lesser Omentum: A Unique Case Report and Literature Review. Medicine (Baltimore). 2016;95(14):e3246. Ling Q Xu X Wang B Li L Zheng S. The Origin of New-Onset Diabetes After Liver Transplantation: Liver Islets or Gut? Transplantation. 2016;100(4):808-13. Zhang W Zhong H Zhuang L Yu J Xu X Wang W Zhang M Zhou L Zheng S. Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post-DCD liver transplant. Int J Clin Pract. 2016;70 Suppl 185:11-6. Zhou J Hu Z Zhang Q Li Z Xiang J Yan S Wu J Zhang M Zheng S. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One. 2016;11(5):e0155179. Wei Q Xu X Wang C Zhuang R Zhuang L Zhou L Xie H Wu J Zhang M Shen Y Wang W Zheng S. Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. Gut Liver. 2016; 10(4):604-10 Shi S Xia W Guo H Kong H Zheng S. Unique characteristics of pyogenic liver abscesses of biliary origin. Surgery. 2016;159(5):1316-24. Ling Q Xu X Xie H Wang K Xiang P Zhuang R Shen T Wu J Wang W Zheng S. New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry. Liver Int. 2016;36(5):705-12. Chen HY Chen YM Wu J Yang FC Lv Z Xu XF Zheng SS. Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study. Medicine (Baltimore). 2016;95(21):e3708. Zhang W Xie HY Ding SM Xing CY Chen A Lai MC Zhou L Zheng SS. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2016;15(3):289-96. Geng L Lin BY Shen T Guo H Ye YF Zheng SS. Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative. Hepatobiliary Pancreat Dis Int. 2016;15(3):316-8. Hu Z Zhong X Zhou J Xiang J Li Z Zhang M Wu J Jiang W Zheng S. Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience. Sci Rep. 2016;6:26487. Tu Z Xiang P Xu X Zhou L Zhuang L Wu J Wang W Zheng S. DCD liver transplant infection: experience from a single centre in China. Int J Clin Pract. 2016;70 Suppl 185:3-10. Zhang ML Xu J Zhang W Liu XY Zhang M Wang WL Zheng SS. Microbial epidemiology and risk factors of infections in recipients after DCD liver transplantation. Int J Clin Pract. 2016;70 Suppl 185:17-21. Wan DL Zhai ZL Ren KW Yang YC Lin SZ Zheng SS. Hepatic schwannoma: A case report and an updated 40-year review of the literature yielding 30 cases. Mol Clin Oncol. 2016 Jun;4(6):959-964. Cheng S Luo M Ding C Peng C Lv Z Tong R Xiao H Xie H Zhou L Wu J Zheng S. Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma. Gene. 2016;591(1):236-44. Xu X Lu D Zhuang R Wei X Xie H Wang C Zhu Y Wang J Zhong C Zhang X Wei Q He Z Zhou L Zheng S. The phospholipase A2 activity of peroxiredoxin 6 promotes cancer cell death induced by tumor necrosis factor alpha in hepatocellular carcinoma. Mol Carcinog. 2016 ;55(9):1299-308. Zhang Q Tian Y Duan J Wu J Yan S Chen H Meng X Owusu-Ansah KG Zheng S. Chelerythrine ameliorates acute cardiac allograft rejection in mice. Transpl Immunol. 2016;38:78-83. Cheng S Jiang X Ding C Du C Owusu-Ansah KG Weng X Hu W Peng C Lv Z Tong R Xiao H Xie H Zhou L Wu J Zheng S. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. Int J Mol Sci. 2016;17(8). Xiao H Tong R Yang B Lv Z Du C Peng C Ding C Cheng S Zhou L Xie H Wu J Zheng S. TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma. Cancer Lett. 2016;381(2):370-379. Yin S Chen X Xie H Zhou L Guo D Xu Y Wu L Zheng S. Nanosecond pulsed electric field (nsPEF) enhance cytotoxicity of cisplatin to hepatocellular cells by microdomain disruption on plasma membrane. Exp Cell Res. 2016;346(2):233-40. Xu X Liu Z Wang J Ling Q Xie H Guo H Wei X Zhou L Zheng S. miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats. Sci Rep. 2016;6:31267. Wang J Wang H Li J Liu Z Xie H Wei X Lu D Zhuang R Xu X Zheng S. iRGD-Decorated Polymeric Nanoparticles for the Efficient Delivery of Vandetanib to Hepatocellular Carcinoma: Preparation and in Vitro and in Vivo Evaluation. ACS Appl Mater Interfaces. 2016;8(30):19228-37. Gao F Zhu HK Zhu YB Shan QN Ling Q Wei XY Xie HY Zhou L Xu X Zheng SS. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern. Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):371-7. Wang W Ye Y Wang T Zhang F Geng L Yu J Zhou L Yan S Zheng S. Prognostic prediction of male recipients selected for liver transplantation: With special attention to neutrophil to lymphocyte ratio. Hepatol Res. 2016;46(9):899-907. Li Z Mei S Xiang J Zhou J Zhang Q Yan S Zhou L Hu Z Zheng S. Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts. Sci Rep. 2016;6:29298. Wu Y Zhou D Xu X Zhao X Huang P Zhou X Song W Guo H Wang W Zheng S. Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma. World J Surg Oncol. 2016 Jul 7;14(1):179. Hu Z Qian Z Wu J Zhou J Zhang M Zhou L Zheng S. Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation. Clin Res Hepatol Gastroenterol. 2016;40(3):315-26. Xu X Lu D Ling Q Wei X Wu J Zhou L Yan S Wu L Geng L Ke Q Gao F Tu Z Wang W Zhang M Shen Y Xie H Jiang W Wang H Zheng S. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2016;65(6):1035-41. Zhang W Xie HY Ding SM Xing CY Chen A Lai MC Zhou L Zheng SS. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):289-96. Pan J Yan S Gao JJ Wang YY Lu ZJ Cui CW Zhang YH Wang Y Meng XQ Zhou L Xie HY Zheng J Zheng MH Zheng SS. In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats. Int J Biochem Cell Biol. 2016;80:124-131. Tian Y Wang J Wang W Ding Y Sun Z Zhang Q Wang Y Xie H Yan S Zheng S. Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation. Stem Cell Res Ther. 2016;7(1):157. Cheng S Luo M Ding C Peng C Lv Z Tong R Xiao H Xie H Zhou L Wu J Zheng S. Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma. Gene. 2016;591(1):236-44. Zhong C Xie HY Zhou L Xu X Zheng SS. Human hepatocytes loaded in 3D bioprinting generate mini-liver. Hepatobiliary Pancreat Dis Int. 2016;15(5):512-518.Zhang WJ Xia WL Pan HY Zheng SS. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes. Hepatobiliary Pancreat Dis Int. 2016;15(5):487-492. Sun K Xu S Wei J Wang B Owusu-Ansah KG Wang W Wu J Zheng S. Clinicopathological features of 11 Epstein-Barr virus-associated intrahepatic cholangiocarcinoma at a single center in China. Medicine (Baltimore). 2016;95(40):e5069. Pan J Yan S Gao JJ Wang YY Lu ZJ Cui CW Zhang YH Wang Y Meng XQ Zhou L Xie HY Zheng J Zheng MH Zheng SS. In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats. Int J Biochem Cell Biol. 2016 Nov;80:124-131. Feng X Jiang J Shi S Xie H Zhou L Zheng S. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Int J Oncol. 2016 Dec;49(6):2600-2610. Wan DL Ren KW Zhang LL Wang B Zhai ZL Zhang XY Yang YC Zheng SS. Liver Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review. Transplant Proc. 2016 Nov;48(9):3197-3202.专利郑树森.利用高压纳秒脉冲治疗人体肝脏肿瘤的手术治疗仪器.发明专利.2012:8/8郑树森.新型胆道支架.实用新型专利.2011:1/6郑树森.肝脏灌注保存装置.实用新型专利.2011:2/2郑树森.胆道支架（全膜-6）.外观设计专利.2011:1/6郑树森.胆道支架（普通-6）.外观设计专利.2011:1/6郑树森.胆道支架（直型5-8）.外观设计专利.2011:1/6郑树森.胆道支架（双猪尾5-5）.外观设计专利.2011:1/6郑树森.胆道支架（圣诞树5-5）.外观设计专利.2011:1/6郑树森.胆道支架（部膜-8）.外观设计专利.2011:1/6郑树森.一种万能供肝的制备方法.发明专利.2013:2/2郑树森.一种载银多层膜涂层胆道支架的制备方法.发明专利.2013:1/6郑树森.一种载银多层膜涂层胆道支架及其制备方法.发明专利.2013:1/6郑树森.充气式无损伤血管阻断牵拉器.发明专利.2015:3/3郑树森.皮下充气式引流支撑架.发明专利.2016:3/3郑树森.一种多肽及包含该多肽的核酸药物纳米粒.发明专利.2016:7/7郑树森.一种紫杉烷类药物前体.发明专利.2016:6/6郑树森.胆管结石取石术中用于降低腹腔感染率的防护装置.发明专利.2016:3/3郑树森.一种辣椒碱-喜树碱类抗癌药物偶联物及其制备方法和应用.发明专利.2016:5/5郑树森.缺血下肢控制性灌流系统及其方法.发明专利.2016:9/9郑树森.一种生物样本冻存管.实用新型专利.2014:5/5郑树森.肝移植术中供肝快速固定灌注装置.发明专利.2017:3/3奖励荣誉:荣获国家科技进步特等奖1项；一等奖(含创新团队奖)2项；国家科技进步二等奖2项；荣获2013年度何梁何利基金“科学与技术进步奖”主持的“肝癌肝移植新型分子分层体系研究”这项创新性研究获得2016年度中国高等学校十大科技进展；荣获2016年度中央电视台年度科技创新人物。 